Altered VEGF Splicing Isoform Balance in Tumor Endothelium Involves Activation of Splicing Factors Srpk1 and Srsf1 by the Wilms’ Tumor Suppressor Wt1

Antiangiogenic therapy: Markers of response, “normalization” and resistance

(2018) Karima El Alaoui-Lasmaili et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Organotypic vasculature: From descriptive heterogeneity to functional pathophysiology

(2017) Hellmut G. Augustin et al.   SCIENCE

RNA Activation of the Vascular Endothelial Growth Factor Gene (VEGF) Promoter by Double-Stranded RNA and Hypoxia: Role of NoncodingVEGFPromoter Transcripts

(2016) Pascal Lopez et al.   MOLECULAR AND CELLULAR BIOLOGY

MDA-MB-231 breast cancer cells overexpressing single VEGF isoforms display distinct colonisation characteristics

(2015) Melanie Di Benedetto et al.   BRITISH JOURNAL OF CANCER

An antiangiogenic isoform of VEGF-A contributes to impaired vascularization in peripheral artery disease

(2014) Ryosuke Kikuchi et al.   NATURE MEDICINE

The Wilms’ tumour suppressor Wt1 is a major regulator of tumour angiogenesis and progression

(2014) Kay-Dietrich Wagner et al.   Nature Communications

The Telomeric Protein TRF2 Regulates Angiogenesis by Binding and Activating the PDGFRβ Promoter

(2014) Mounir El Maï et al.   Cell Reports

WT1 regulates murine hematopoiesis via maintenance of VEGF isoform ratio

(2013) T. J. Cunningham et al.   BLOOD

Endothelial, epithelial, and fibroblast cells exhibit specific splicing programs independently of their tissue of origin

(2013) P. Mallinjoud et al.   GENOME RESEARCH

HnRNP A1/A2 and SF2/ASF Regulate Alternative Splicing of Interferon Regulatory Factor-3 and Affect Immunomodulatory Functions in Human Non-Small Cell Lung Cancer Cells

(2013) Rong Guo et al.   PLoS One

WT1 Mutants Reveal SRPK1 to Be a Downstream Angiogenesis Target by Altering VEGF Splicing

(2011) Elianna M. Amin et al.   CANCER CELL

Mouse Knockout of the Cholesterogenic Cytochrome P450 Lanosterol 14α-Demethylase (Cyp51) Resembles Antley-Bixler Syndrome

(2011) Rok Keber et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Endogenous Vascular Endothelial Growth Factor-A (VEGF-A) Maintains Endothelial Cell Homeostasis by Regulating VEGF Receptor-2 Transcription

(2011) Guangqi E et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

WT1 Protein Directly Regulates Expression of Vascular Endothelial Growth Factor and Is a Mediator of Tumor Response to Hypoxia

(2011) Gregory McCarty et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Functional and Structural Characteristics of Tumor Angiogenesis in Lung Cancers Overexpressing Different VEGF Isoforms Assessed by DCE- and SSCE-MRI

(2011) Ang Yuan et al.   PLoS One

Isolation and Culture of Pulmonary Endothelial Cells from Neonatal Mice

(2010) Magdalena Sobczak et al.   Jove-Journal of Visualized Experiments

Regulation of Vascular Endothelial Growth Factor (VEGF) Splicing from Pro-angiogenic to Anti-angiogenic Isoforms

(2009) Dawid G. Nowak et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

VEGF165b, an antiangiogenic VEGF-A isoform, binds and inhibits bevacizumab treatment in experimental colorectal carcinoma: balance of pro- and antiangiogenic VEGF-A isoforms has implications for therapy

(2008) A H R Varey et al.   BRITISH JOURNAL OF CANCER

Expression of pro- and anti-angiogenic isoforms of VEGF is differentially regulated by splicing and growth factors

(2008) D. G. Nowak et al.   JOURNAL OF CELL SCIENCE

Human Papillomavirus Type 16 E2 Protein Transcriptionally Activates the Promoter of a Key Cellular Splicing Factor, SF2/ASF

(2008) S. Mole et al.   JOURNAL OF VIROLOGY

A Sliding Docking Interaction Is Essential for Sequential and Processive Phosphorylation of an SR Protein by SRPK1

(2008) Jacky Chi Ki Ngo et al.   MOLECULAR CELL

The Wilms' tumour suppressor WT1 is involved in endothelial cell proliferation and migration: expression in tumour vessels in vivo

(2008) N Wagner et al.   ONCOGENE